• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lianbio ADR (NQ: LIAN )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Mar 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Lianbio ADR

    < Previous 1 2 3 4 Next >
    The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus ImmunityBio Says Cancer Combo Therapy Produces Positive Results In Late-Stage... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap... 
    Via Benzinga
    41 Biggest Movers From Yesterday
    Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave... 
    Via Benzinga
    New Beijing Signals Reinforce China's Intent to Reopen U.S. IPO Pipeline
    Key Takeaways: China Securities Regulatory Commission Chairman Yi Huiman says his agency is aiming to quickly implement new rules government overseas listings by Chinese firms... 
    Via Benzinga
    48 Biggest Movers From Yesterday
    Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... 
    Via Benzinga
    46 Biggest Movers From Yesterday
    Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on... 
    Via Benzinga
    36 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal... 
    Via Benzinga
    50 Biggest Movers From Yesterday
    Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial... 
    Via Benzinga
    A Peek Into The Markets: US Stock Futures Tumble Amid COVID-19 Jitters
    Pre-open movers U.S. stock futures traded lower in early pre-market trade after a new COVID-19 variant was detected in South Africa. Investors are awaiting earnings results from... 
    Via Benzinga
    Exposures COVID-19
    Benzinga's Top Ratings Upgrades, Downgrades For November 24, 2021
    Upgrades For Aegon NV (NYSE:... 
    Via Benzinga
    The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
    Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the... 
    Via Benzinga
    Exposures Product Safety
    Medical Device Maker Highlights China Risk as Chinese U.S. IPOs Resume
    Key Takeaways: Meihua International files updated prospectus highlighting China oversight risk in latest filing for its modest $57 million U.S. IPO Hotel operator Atour makes... 
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    Week In Review: Two China Affiliated Biopharmas Raise $585 Million In IPOs
    LianBio raised $325 million in its Nasdaq IPO at a market capitalization of $1.9 billion to support its drug in-licensings for China. Beijing Clover Biopharma also completed a $260 million IPO in Hong... 
    Via Talk Markets
    Topics Initial Public Offering
    Exposures Securities Market
    China-U.S. IPO Pipeline Creaks Back To Life With Two New Listing Plans
    Key takeaways: Two Chinese companies, drug maker LianBio and hotel operator Autour, are moving ahead with U.S. IPOs after a three-month pause on such listings Neither company is... 
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    64 Biggest Movers From Yesterday
    Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.